Melanoma is the deadliest form of skin cancer because of its propensity to spread beyond the primary site of disease and because it resists many forms of treatment. Incidence of melanoma has been increasing for decades. Though ultraviolet radiation (UV) has been identified as the most important environmental causative factor for melanoma development, UV-protective strategies have had limited efficacy in melanoma prevention. UV mutational burden correlates with melanoma development and tumor progression, underscoring the importance of UV in melanomagenesis. However, besides amount of UV exposure, melanocyte UV mutational load is influenced by the robustness of nucleotide excision repair, the genome maintenance pathway charged with removing UV photoproducts before they cause permanent mutations in the genome. In this review, we highlight the importance of the melanocortin hormonal signaling axis on regulating efficiency of nucleotide excision repair in melanocytes. By understanding the molecular mechanisms by which nucleotide excision repair can be increased, it may be possible to prevent many cases of melanoma by reducing UV mutational burden over time.
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Melanoma -risk determinants
Inherited and environmental factors heavily influence melanoma risk (Table 1 ; please see (7) for a comprehensive review). Genetic risk factors include number and nature of nevi as well as prior diagnosis of melanoma in the family. Some genes that are known to influence melanoma risk include CDKN2A, CDK4, MITF and variants in pigmentation loci or DNA repair genes (8-11). Other inherited traits that are controlled by multiple loci are number and nature of nevi (12) and immunocompetence of T cell responses (13) .
A wealth of epidemiologic and molecular data point to ultraviolet radiation (UV) as the most important environmental risk factor for melanoma (14) . Many melanomas arise from nevi on sun-exposed anatomic areas of the body (15) (16) (17) , melanoma incidence increases with geographic proximity to the equator where the sun's rays are strongest (18), and tanning bed use clearly increases melanoma risk (19, 20) . Moreover, at least two landmark studies have documented that melanoma has more somatic (non-germline) mutations than any other cancer and that the great majority of mutations are "UV-signature" base changes in adjacent pyrimidines (21, 22) . Recently, the Bastian group documented that somatic mutational burden increases with melanoma tumor progression and that at least 80% of mutations are UV-signature mutations (23) . Therefore, the amount of exposure of a melanocyte to UV and its ability to resist UVinduced DNA mutations should have a direct impact on the likelihood of transformation into malignant melanoma.
Ultraviolet Radiation and its effects on cells
The International Agency for Research on Cancer (IACR) classifies UV as a "Group 1" carcinogen, meaning that there is irrefutable evidence that UV causes cancer in humans (24) . Unlike many other carcinogens that are chemical in nature, UV consists of photons whose wavelength and energy fall between ionizing radiation (X rays) and visible light (Fig. 3) . The sun is the natural source of UV,
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This article is protected by copyright. All rights reserved. although significant UV exposure can be obtained by artificial UV sources in the form of tanning beds (25) . Since water vapor and particles in the atmosphere can absorb or deflect UV photons, UV in sunlight becomes attenuated when it travels through the atmosphere. Thus, solar UV energy is strongest in those places on Earth at the equator where the sun hits the Earth directly and at high altitudes where the land reaches highest into the sky. UV can be subdivided by wavelength and energy into UV-A (315-400 nm; 3.10 -3.94 eV/photon), UV-B (280-315 nm; 3.94 -4.43 eV/photon) and UV-C (200-280 nm; 4.43 -12.4 eV/photon). In most places on Earth, ambient sunlight consists of >90% UV-A with the remainder UV-B because atmospheric ozone effectively absorbs shorter-wavelength UV-C energy.
UV energy is highly bioactive, exerting physico-chemical changes that damage and/or cross-link a variety of cellular macromolecules such as lipids, RNA, DNA and protein (26) . Using a murine model with "humanized skin", Noonan and coworkers showed that melanomas could be initiated by UV-A or UV-B radiation (27) , therefore melanocyte carcinogenesis can be promoted across the UV spectrum. Longer wavelength UV promotes the formation of singlet oxygen ( 1 O 2 ) which oxidizes molecules in lipids, amino acids as well as nucleotide bases in RNA and DNA (28) . In general, these changes interfere with the function of macromolecules and in many cases lead to their premature destruction (29) . While lipids, RNA and protein are renewable molecules that can be replaced when damaged, DNA cannot simply be replaced and must be repaired (30) . Indeed, the repair of DNA must happen in a timely manner because many of the UV changes interfere with the function of polymerases and/or cause errant base pairing which yields RNAs and proteins of inappropriate sequence and function. More serious, however, is errant base pairing during cell division. In this manner unrepaired UV-induced DNA changes introduce mutations into the genome of daughter cells. Oxidation-mediated changes to nucleotide bases, for the most part, are dealt with by the base excision repair (BER) pathway wherein specific oxidatively generated lesions are recognized and removed from the DNA by lesion-specific glycosylases without breaking the sugar-phosphate backbone to generate an apurinic site which is then filled in using the undamaged sister strand as a template.
UV photons also promote the formation of covalent base changes in DNA at sites of neighboring pyrimidines by breaking existing C5/C6 bonds in cytosines or thymines. Wavelengths in the UV-B range generate cyclobutane pyrimidine dimers (CPDs) and to a lesser extent pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) whereas those in the UV-A range promote CPD formation rather than 6-4PPs.
UV-A photons also efficiently promote photoisomerization of 6-4PPs into Dewar valence isomers (31) .
All of these photolesions block transcription and DNA replication, activate cell cycle checkpoints, stimulate mutagenesis and chromosomal rearrangements and can promote apoptosis. If left unrepaired, photolesions cause transition mutations (e.g. CC-to-TT) known as "UV-signature mutations" which are found in abundance in melanoma isolates (32) . Indeed, the high degree of UV-signature mutations in melanoma is among the strongest pieces of molecular evidence linking UV with the disease (21-23).
Recently, a paradigm-shifting insight was made regarding how photoproducts form after UV exposure. It had long been observed that although UV photoproducts can be identified in cells immediately following UV exposure, their levels increase for some time after the UV exposure ends. Brash and co-workers termed these lesions "dark CPDs" and reported that they arise when UV-induced reactive oxygen and nitrogen species combine to excite an electron in fragments of melanin that creates a quantum triplet state that has the energy of a UV photon. Triplet-state melanin induces CPDs by energy transfer to DNA in a radiation-independent manner up to several hours after UV exposure ends (33) . Indeed, their data suggest that the majority of all UV-mediated CPDs in melanocytes might occur through this process of melanin chemiexcitation and dark CPD formation (Fig. 5 ). This new insight into UV-mediated DNA lesion formation has many implications regarding mechanisms of UV resistance and genome maintenance.
Indeed, innate UV-activated systems that enhance the efficiency of DNA repair, such as up-regulation of the melanocortin signaling axis (discussed below), may be most relevant for the repair of dark CPDs.
Melanocortin 1 receptor (MC1R) and cAMP signaling
Melanocytes are long-lived cells that must, as a result of their anatomic location in the skin, cope with environmental insults such as UV radiation. They must not only survive following UV exposure, but they must also respond physiologically to ramp up melanin production to protect the skin against further UV damage. Much of their ability to respond appropriately to UV is regulated by the melanocortin 1 receptor Melanin produced by melanocytes is transferred to keratinocytes where it accumulates in the epidermis to protect deep layers of the skin from UV damage. In this way, MC1R directly controls the adaptive
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tanning response which is critical for cutaneous UV protection (40, 55). MC1R activation also enhances melanocytes' ability to resist UV damage, as will be discussed in detail below.
Not only can MC1R signaling be enhanced by ligand-receptor interactions with either α-MSH or ACTH, it can also be inhibited by physical interactions with either of two physiologic antagonists: human betadefensin 3 (βD3) or agouti signaling protein (ASIP) (56, 48). βD3 acts as a neutral antagonist, interfering with melanocortin binding to MC1R and preventing cAMP increases in the presence of α-MSH or ACTH (57). In contrast, ASIP is a negative agonist, not only inhibiting melanocortin-mediated MC1R activation but also down-regulating ligand-independent MC1R signaling (58). Whereas ASIP is not thought to be physiologically relevant in human skin (59), βD3 is robustly expressed in a variety of circumstances including inflammation and infection (60) (61) (62) (63) . Thus regulation of melanocyte cAMP levels and the functional downstream consequences of melanin production and DNA repair may be dynamic and multifaceted, being regulated by ligand-independent signaling as well as positive and negative ligands.
Nucleotide excision repair
DNA repair is essential for maintaining the integrity of the genome, which when faulty contributes to mutagenesis, genetic instability and carcinogenesis. Nucleotide excision repair is the primary system for removing UV-induced damage such as CPDs and 6-4PPs. The xeroderma pigmentosum complementation group proteins (XPs) play a critical role in coordinating and promoting nucleotide excision repair (reviewed in (64) (65) (66) ). In elegant in vitro experiments, the Wood and Sancar labs independently reported the molecular requirements for reconstitution of nucleotide excision repair in vitro (67, 68) . In global genomic repair (GG-nucleotide excision repair), the recognition of helical distorting lesions is achieved by XPC-RAD23B (69), and in some cases UV-DDB (70) . Initial events in lesion recognition remain somewhat unclear with several studies supporting a model of initial recognition by XPC followed by binding of TFIIH, XPA and RPA (71-74), but it is generally accepted that the XPC/HR23B complex is recruited to photodamage by interactions with the undamaged complementary strand (64) . In
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transcription-coupled repair (TC-nucleotide excision repair) a blocked RNA polymerase acts as the damage recognition signal. TC-nucleotide excision repair and GG-nucleotide excision repair differ in damage recognition but subsequent steps converge into one repair pathway (Fig. 8) . After damage recognition, there is recruitment of transcription factor II H (containing XPB and XPD) leading to strand separation to facilitate binding of other nucleotide excision repair factors including XPA, replication protein A (RPA), XPG and excision repair cross-complementation group 1 (ERCC1)-XPF (75, 76) . Once ERCC1-XPF is positioned on DNA via its interaction with XPA (77), it cuts the damaged strand 5' to the lesion (77), followed by XPG incising 3' to the damage (78) . DNA is restored to its original form (with preservation of original sequence) by the action of DNA polymerases (e.g. Polδ and Polκ) and associated factors using the undamaged complementary strand as a template (79) . Failure to fill the gap leads to activation of cellular damage responses (80) .
Xeroderma Pigmentosum (XP)
The importance of nucleotide excision repair in cancer resistance is best illustrated by considering the natural history of patients with XP, a rare UV hypersensitivity syndrome caused by homozygous defects in certain components of the pathway: XPA, ERCC1, ERCC3 (XP-B), XPC, ERCC2 (XPD), DDB2
(XPE), ERCC4 (XPF), ERCC5 (XPG) and POLH (81) . XP patients demonstrate hyper UV sensitivity and develop characteristic skin changes including pigmentary abnormalities, capillary telangiectasias and atrophy on UV-exposed anatomic sites at very early ages (82) . Premalignant lesions and skin cancers develop at high frequency and much sooner than in unaffected persons. Melanomas, basal cell carcinomas and squamous cell carcinomas typically develop before the second decade of life, many years before the general population (83) . In addition, XP-associated skin cancers frequently demonstrate "UV signature mutations", clearly indicating the importance of nucleotide excision repair in resisting cancers caused by UV (84) .
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This article is protected by copyright. All rights reserved. ATR to associate with the key nucleotide excision repair factor XPA (46). Together, XPA and ATRpS435 co-localize to sites of UV-induced DNA damage in an accelerated and enhanced manner (Fig. 9) .
Loss of S435 within ATR prevents PKA-mediated ATR phosphorylation, disrupts ATR-XPA binding, delays recruitment of XPA to UV-damaged DNA and elevates UV-induced mutagenesis in melanocytes.
This article is protected by copyright. All rights reserved. 
Hormonal regulation of nucleotide excision repair by MC1R agonists and antagonists
Having previously established that MC1R-enhanced nucleotide excision repair is dependent on PKAmediated phosphorylation of ATR on S435, recruitment of XPA and accelerated localization to nuclear UV photodamage (46), we sought to determine the influence of physiologic MC1R ligands on ATRpS435 accumulation and nucleotide excision repair function (48). In order to study the kinase activity of the MC1R-cAMP-PKA axis, high throughput methodologies were developed. ATR-pS435 was detected in vitro using a 14-mer peptide (consisting of residues 428-441 of ATR) using a phospho-specific (ATRpS435) antibody. In melanocytes with intact MC1R signaling, the ATR-pS435-XPA axis is heavily To elucidate the functional effect of MC1R ligands on DNA repair, the oligonucleotide retrieval assay that quantifies repair by PCR-based amplification was adapted (97). In this assay, the presence of photoproduct(s) interferes with the DNA polymerase; therefore, the amount of amplification across the oligonucleotide is proportional to clearance of photolesions by nucleotide excision repair. We adapted this
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method by directly UV-irradiating the oligonucleotide (instead of a chemically-generated single CPD lesion) which resulted in more CPDs and 6-4PPs (48). We observed that nucleotide excision repair responses were regulated by MC1R status and ligand interactions and that they correlated with ATRpS435 accumulation and XPA-DNA binding (48). Thus, α-MSH promoted nucleotide excision repair while ASIP and βD3 blocked α-MSH-mediated enhancement of repair. ASIP blunted repair of UVinduced DNA damage to a greater extent than βD3, which is explained by the fact that ASIP has a greater ability to inhibit ATR-pS435 generation than βD3. Together, these findings support the hypothesis that MC1R/cAMP signaling controls melanocytic nucleotide excision repair through downstream PKAmediated ATR phosphorylation on S435. Furthermore, these data raise the possibility that dysregulated expression of ASIP or βD3 in the skin may impair DNA repair responses in melanocytes to heighten UV mutagenesis and melanoma risk.
MC1R as a melanoma risk determinant
It has been known for many years that inherited signaling defects in MC1R correlate with melanoma risk (37, 98-100). While MC1R loss certainly yields a UV-sensitive fair complexion phenotype, it is clear that melanocyte genome stability is reduced as a result of MC1R loss. Indeed, a recent study established a role for germline loss-of-function MC1R variants in increasing the somatic mutational landscape of melanoma (101). Because of MC1R's role in regulating melanocyte UV responses (102, 103), it is not surprising that inherited MC1R signaling defects impact melanoma susceptibility (Fig. 10) .
The human MC1R gene is highly polymorphic with over 100 variants reported (104). Though many mutants affect its signaling ability, five in particular -the so-called "red hair variants" (or "RHC variants") -D84E, R142H, R151C, R160W, and D294H -are especially associated with increased melanoma risk (105, 106). When MC1R signaling is blunted, melanocytes are less able to respond to α-MSH or ACTH and cytoplasmic cAMP levels are lower. Instead of robust production of a brown/black UV-blocking pigment known as eumelanin, there is production of a pigment variant known as
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pheomelanin, which is a red/blonde melanin bioaggregate that is less able to block UV radiation and actually promotes free radical formation (107). Indeed, pheomelanin is an independent melanoma risk factor (108) therefore MC1R deficiency influences mutagenic risk not only because of diminished eumelanin formation, but also because of increased pheomelanin production. MC1R deficiency also results in less effective nucleotide excision repair (43, 46-48), therefore, MC1R defects contribute to melanoma development not only by permitting more UV damage in melanocytes but also by blunting the ability of melanocytes to repair that damage.
Translational implications
The MSH-MC1R signaling axis is an innate melanocyte protective pathway recruited after UV exposure to help melanocytes recover from damage and protect the skin against further UV damage. Persons with inherited defects in MC1R signaling function suffer higher melanoma risk because of sub-optimal melanization and defective DNA repair, each of which leads to accumulation of UV-induced mutations known to be causative for melanoma. Because MC1R-mediated melanization and enhanced genome maintenance are dependent on cellular cAMP levels, it is possible to pharmacologically stimulate MC1R responses to protect MC1R-impaired individuals from UV-induced mutagenesis by manipulating melanocyte cAMP levels. There are two fundamental approaches to achieve this: (1) those that specifically target melanocytes by taking advantage of the fact that MC1R expression is limited to melanocytes in the skin and (2) those that raise cAMP through MC1R-independent mechanisms (Fig. 11 ).
Targeting approaches that limit cAMP induction in melanocytes is important because of the potential for off-target effects of cAMP stimulation on other cells (e.g. keratinocytes) and systems (immune system, circulatory system, etc.). Therefore cutaneous application of agents that mimic melanocortin agonists or that inhibit MC1R antagonists would be expected to increase cAMP levels only in melanocytes because of selective action on MC1R (44). Although these approaches offer melanocyte specificity, neither melanocortin analogues nor inhibitors of MC1R antagonists would be expected to offer benefit to
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This article is protected by copyright. All rights reserved. intracellular loops and a carboxy terminal cytoplasmic tail. The MC1R gene is highly polymorphic; five "red hair color" (RHC) mutations associated with melanoma risk (D84E, R142H, R151C, R160W, and D294H) are indicated. 
This article is protected by copyright. All rights reserved. binding between XPA and ATR in the nucleus and together ATR and XPA localize to UV photodamage in an accelerated and enhanced manner. MC1R agonists α-MSH or ACTH activate PKA-mediated ATR phosphorylation and nucleotide excision repair whereas MC1R antagonists ASIP or βD3 inhibit this repair-enhancing pathway. In this way, genomic stability and susceptibility to UV mutagenesis in melanocytes may be hormonally influenced. in melanocytes enhances UV protection through enhanced melanin production and improved melanocyte genome stability. MC1R-specific approaches include melanocortin analogues or, theoretically, inhibitors of MC1R antagonists such as βD3, but would be expected to be of benefit only for individuals with intact
